Pfizer-BioNTech begin late-stage study of lead COVID-19 vaccine candidate

Title:
Pfizer-BioNTech begin late-stage study of lead COVID-19 vaccine candidate

Authors:
Vishwadha Chander & Carl O'Donnell

Publsihed:
Reuters, 28 July 2020
https://www.reuters.com/article/us-health-coronavirus-pfizer-biontech/pfizer-biontech-begin-late-stage-study-of-lead-covid-19-vaccine-candidate-idUSKCN24S2Q9

From the article:
German biotech BioNTech and U.S. drugmaker Pfizer Inc said on Monday they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.

University of Oxford & AstraZeneca - Oxford-AstraZeneca Covid vaccine study shows dual immune action

Title:
Oxford-AstraZeneca Covid vaccine study shows dual immune action

By:
Bloomberg

Published:
Maverick Citizen, 20 July 2020
https://www.dailymaverick.co.za/article/2020-07-20-oxford-astrazeneca-covid-vaccine-study-shows-dual-immune-action/#gsc.tab=0

From the article:
A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.

University of Oxford - Covid-19 Vaccine Front-Runner is Months Ahead of Her Competition

Title:
Covid Vaccine Front-Runner is Months Ahead of Her Competition

Title:
Stephanie Baker

Published:
Bloomberg Businessweek, 15 July 2020
https://www.bloomberg.com/news/features/2020-07-15/oxford-s-covid-19-vaccine-is-the-coronavirus-front-runner

From the article:
The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?

Coronavirus vaccine might be ready in first half of 2021 if things go ‘extraordinarily well’, says Imperial College professor [Independent, 10 June 2020]

Title:
Coronavirus vaccine might be ready in first half of 2021 if things go ‘extraordinarily well’, says Imperial College professor

Author:
Samuel Lovett

Published:
Independent, 10 June 2020
https://www.independent.co.uk/news/health/coronavirus-vaccine-imperial-college-oxford-trial-uk-covid-19-a9558456.html

From the article:
A Covid-19 vaccine being developed by scientists at Imperial College London could be ready and available in the first half of 2021, according to the team’s leading professor.

Vaccine for COVID-19 safe, effective in first human clinical trial, study says: The Phase I study in China included 108 patients, and a Phase II study already is underway

Title:
Vaccine for COVID-19 safe, effective in first human clinical trial, study says

Author:
Brian P Dunleavy

Published:
UPI, 22 May 2020
https://www.upi.com/Health_News/2020/05/22/Vaccine-for-COVID-19-safe-effective-in-first-human-clinical-trial-study-says/2631590154893/

From the article:
"A potential vaccine for COVID-19 appears to be safe and able to generate an immune response against the virus, according to a study published Friday by The Lancet.  

The new study marks the first time the vaccine was tested in humans."

US Biotech Firm Kicks Off COVID Vaccine Tests on Humans After Receiving $388Mln From Bill Gates Fund (Sputnik News, 26 May 2020)

Title:
US Biotech Firm Kicks Off COVID Vaccine Tests on Humans After Receiving $388Mln From Bill Gates Fund

Published:
Sputnik News, 26 May 2020
https://sputniknews.com/science/202005261079417707-us-biotech-firm-kicks-off-covid-vaccine-tests-on-humans-after-receiving-388mln-from-bill-gates-fund/

From the article:
"US biotech firm Novavax said in a statement it has started testing a new coronavirus vaccine on humans, and is currently in phase one clinical trials, having enjoyed a massive grant from an agency founded by Bill Gates."